Stanford University
Showing 6,401-6,500 of 13,130 Results
-
Craig Levin
Professor of Radiology (Molecular Imaging Program at Stanford/Nuclear Medicine) and, by courtesy, of Physics, of Electrical Engineering and of Bioengineering
Current Research and Scholarly InterestsMolecular Imaging Instrumentation
Laboratory
Our research interests involve the development of novel instrumentation and software algorithms for in vivo imaging of cellular and molecular signatures of disease in humans and small laboratory animal subjects. -
Eleanor Levin
Clinical Professor, Medicine - Cardiovascular Medicine
Current Research and Scholarly InterestsCardiovascular Value Based Care, Cardio-Obstetrics, Dyslipidemia Treatment
-
Joshua Levin, MD
Clinical Professor, Orthopaedic Surgery
Clinical Professor, NeurosurgeryBioDr. Levin completed a residency in physical medicine and rehabilitation at the University of Michigan in 2007, and a pain medicine fellowship at the Virginia Commonwealth University in 2008. Currently, he is a member of both the departments of orthopedic surgery and neurosurgery at Stanford University, where he also is the director of the PM&R residency program and the associate director of the interventional spine and musculoskeletal medicine fellowship.
-
Peter Levin, MD
Clinical Instructor, Ophthalmology
BioDr. Levin is a board-certified, fellowship-trained ophthalmologist with the Stanford Health Care Byers Eye Institute. He is also a clinical instructor in the Department of Ophthalmology at Stanford University School of Medicine.
Dr. Levin has focused solely on plastic and reconstructive eye surgery since 1992. He evaluates and cares for conditions such as tear duct problems and eyelid problems, including eyelid growths and cancers. As an established expert, he uses the best techniques to improve eye health and confidence in facial appearance.
Dr. Levin has published research findings in many peer-reviewed journals, including the American Journal of Ophthalmology and Archives of Ophthalmology. He has also shared his expertise at numerous ophthalmology conferences and in books such as Contemporary Issues in Ophthalmology and Ophthalmic Surgical Procedures.
He is a fellow of the American Society of Ophthalmic Plastic and Reconstructive Surgery and the American Academy of Ophthalmology. He also has a long history of teaching about ophthalmic procedures at Stanford University School of Medicine. -
Deborah J Levine, MD, FCCP, FAST
Clinical Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
BioDr. Deborah Jo Levine is a board-certified pulmonologist and lung transplantation and pulmonary hypertension specialist. She is a clinical professor of medicine in the Department of Pulmonary, Allergy, and Critical Care Medicine. Dr. Levine also serves as director of lung transplant outreach for Stanford Health Care.
Dr. Levine is internationally recognized for her work in lung transplantation and pulmonary hypertension (PH). She has been instrumental in developing international guidelines for defining, diagnosing, and managing antibody-mediated rejection (AMR) after lung transplantation. She has served as chair of pulmonary AMR guidelines for the International Society of Heart and Lung Transplantation.
Dr. Levine’s research interests include lung allograft monitoring and risk assessment. Her research has also included monitoring lung allograft health using donor-derived cell-free DNA (dd-cfDNA)—a technique pioneered at Stanford Medicine. She has received National Institutes of Health (NIH) funding as a clinical investigator. Dr. Levine is a co-chair of the ALAMO (AlloSure Lung Assessment and Metagenomics Outcomes) Study national registry. She has been involved in many clinical trials in lung transplantation and pulmonary hypertension.
As a respected educator and researcher, Dr. Levine has led and contributed to dozens of abstracts, presentations, and peer-reviewed articles. She has also written several books and book chapters on pulmonary hypertension, interstitial lung disease, pulmonary vascular disorders, and lung transplantation.
Dr. Levine is editor-in-chief for Advances in Pulmonary Hypertension, the quarterly journal of the Pulmonary Hypertension Association. She is an editorial board member of The Journal of Heart and Lung Transplantation and an ad hoc reviewer for several other industry journals. Dr. Levine also serves as a grant reviewer and section study reviewer for the American College of Chest Physicians and the American Society of Transplantation.
Dr . Levine is a fellow of the American College of Chest Physicians and the American Society of Transplantation. She is also the chair of the Diffuse Lung Disease and Lung Transplant Network and the incoming vice chair of the Council of Networks for the American College of Chest Physicians (CHEST). -
Shana Charlie Levine
Clinical Research Coordinator Associate, Multispecialty Anesthesiology
Current Role at StanfordCRCA with Dr. Jennifer Hah's Strategies for Pain Alleviation though Research and Knowledge for Long-term Efficacy (SPARKLE✨) Lab
Stanford University School of Medicine
Department of Anesthesiology, Perioperative and Pain Medicine | Division of Pain Medicine -
Douglas F. Levinson, M.D.
Walter E. Nichols, M.D. Professor in the School of Medicine, Emeritus
Current Research and Scholarly InterestsDr. Levinson directs the Program on the Genetics of Brain Function in the Department of Psychiatry and Behavioral Sciences. The program investigates the genetic basis of psychiatric disorders (schizophrenia and major depressive disorder), using genetic association, linkage and resequencing methodologies. In collaboration with Dr. Alice Whittemore, we are also actively engaged in statistical methods testing and development for genetic research.
-
Simon Levinson
Affiliate, Department Funds
Resident in NeurosurgeryBioSimon was born and raised in and around New York City. He moved to California to attend the University of California, Los Angeles (UCLA) where he obtained undergraduate degrees in both political theory and neuroscience. Simon continued his education at UCLA where he attended the David Geffen School of Medicine. While a medical student he worked under the mentorship of Dr. Carlos Cepeda to investigate the cellular mechanisms underlying pediatric epilepsy. Additionally, under the mentorship of Dr. Ausaf Bari he created an MRI based structural atlas of the human brainstem. Simon is currently undergoing clinical training in neurologic surgery at Stanford University. He is interested in understanding how neural networks function and contribute to disease and how they can aid in developing novel treatment therapies. Outside of medicine, Simon enjoys spending time with his wife, going for hikes with their dog, traveling, listening to audiobooks, and running.
Please see complete publication list on Google scholar profile: https://scholar.google.com/citations?view_op=list_works&hl=en&user=eEX91cwAAAAJ -
Joseph Levitt, MD, MS
Associate Professor of Medicine (Pulmonary and Critical Care Medicine)
Current Research and Scholarly InterestsMy research focuses on the physiolgogic and biomarker characteristics of early acute lung injury (ALI) prior to need for mechanical ventilation. While, to date no pharmacologic treatment has improved survival in ALI, following the paradigm of early goal directed therapy for severe sepsis, clinical benefit may derive from identifying patients and initiating treatment prior to the need for positive pressure ventilation (and therefore prior to meeting current study entry criteria).
-
Lee Levitt
Professor of Medicine (Hematology) at the Santa Clara Valley Medical Center, Emeritus
Current Research and Scholarly InterestsLow molecular-weight heparins Clinical trials with anti-thrombotics Clinical trials in patients with leukemia, breast cancer and myeloma Medical education.
-
Michael Levitt
Robert W. and Vivian K. Cahill Professor of Cancer Research
Current Research and Scholarly InterestsStanford Professor of Biophysics and Computational Biology, Cambridge PhD and DSc, 2013 Chemistry Nobel Laureate (complex systems), FRS & US National Academy member, I code well for my age.
-
Maayan Levy
Assistant Professor of Pathology
Current Research and Scholarly InterestsThe Levy Lab studies how microbiome-brain interactions influence metabolism, behavior, and disease. By investigating how microbial signals affect neural circuits, we explore mechanisms underlying obesity, diabetes, and psychiatric conditions. The lab seeks to uncover new therapeutic targets using advanced neuroscience tools like optogenetics and imaging. Our research aims to improve understanding of how microbiome imbalances contribute to disease and how restoring balance can promote health.
-
Richard Jonathan Levy
Professor of Anesthesiology, Perioperative and Pain Medicine (Pediatric) and, by courtesy, of Pediatrics (Cardiology)
BioRichard J. Levy, MD, FAAP is Professor at Stanford University School of Medicine and Chief of Pediatric Cardiac Anesthesiology at Lucile Packard Children’s Hospital. He has been an NIH-funded clinician-scientist for over 20 years. His laboratory currently investigates the toxicity of anesthetics in the developing brain and heart along with mitochondrial mechanisms of anesthesia. He is currently funded to study and develop a benzoquinone molecule as a novel anesthetic. He is an Associate Editor for Frontiers in Pediatrics, Frontiers in Cardiovascular Medicine, and Survey of Anesthesiology and serves as a regular reviewer for Anesthesiology, British Journal of Anaesthesiology, Critical Care Medicine, Anesthesia & Analgesia, Neurotoxicology and Teratology, PLOS One, The Journal of Thoracic and Cardiovascular Surgery, World Journal for Pediatric and Congenital Heart Surgery, and the American Journal of Physiology. In addition, Dr. Levy has served as an ad hoc reviewer for Science, Nature Medicine, Scientific Reports, and Nature Reviews Cardiology.
-
Ronald Levy, MD
Robert K. and Helen K. Summy Professor in the School of Medicine
Current Research and Scholarly InterestsClinical Interests: lymphoma. Research Interests: Immunology and molecular biology of lymphoid malignancy; molecular vaccines for cancer.
-
Vivian Levy
Clinical Associate Professor (Affiliated), Medicine - Med/Infectious Diseases
Staff, Medicine - Med/Infectious DiseasesBioVivian Levy is Chief of Infectious Diseases at San Mateo Medical Center (SMMC), San Mateo County’s safety net hospital and clinic system in northern California since 2015 and the County’s STD Control Officer since 2006. San Mateo County has 760,000 persons and connects the urban centers of San Francisco and San Jose, California.
Dr. Levy leads Stanford’s Internal Medicine outpatient Infectious Diseases rotation for Internal Medicine residents. She has served 2 terms as president of the California STD/HIV Controllers Association. From 2004-2008, she was the medical officer for the Chemoprophylaxis for HIV prevention in men study in Lima, Peru.
In 2020, she was the San Mateo Medical Center site investigator for the Expanded Access Treatment Protocol: Remdesivir for the Treatment of SARS-CoV2 Infection. She began SMMC patient recruitment for Stanford outpatient COVID studies July 2020 with the goal of increasing historically underrepresented populations participation and access in COVID outpatient treatment trials.
She has an undergraduate degree from Brown University (1989,) an MD from Rush University Medical College in Chicago (1994,) completed internship in Internal Medicine at Cook County Hospital in Chicago (1995) Internal Medicine residency at Northwestern University (1997) and an Infectious Diseases and Geographic Medicine fellowship at Stanford University (2000-2004.) -
David B. Lewis
Naddisy Foundation Professor of Pediatric Food Allergy, Immunology, and Asthma
Current Research and Scholarly InterestsMy laboratory is focused on defining cellular and molecular mechanisms that limit T cell responses to vaccines and pathogens during normal early postnatal development and in cases of inherited genetic immunodeficiencies. We are also determinomg how these limitations in immunity can be overcome by using novel approaches for vaccine adjuvants for influenza vaccine and by using catalytically inactive Cas proteins for inducing endogenous gene expression.
-
Eldrin F. Lewis, MD, MPH
Simon H. Stertzer, MD, Professor
BioDr. Lewis is a board-certified, fellowship-trained specialist in cardiovascular medicine. He is the chief of the Division of Cardiovascular Medicine and a professor of cardiovascular medicine.
Dr. Lewis is an esteemed clinician-scientist who specializes in the care of patients with advanced heart failure. He is an internationally recognized expert on heart failure, heart transplant, and quality of life for heart failure patients. He cares deeply about his patients as well as his colleagues, the hospital, and the School of Medicine. Dr. Lewis is committed to diversity and inclusion, as well as expanding Stanford clinical research initiatives.
A fundamental principle of Dr. Lewis’ practice is his belief that “there is more to life than death,” that cardiovascular care should go beyond helping patients survive to also helping them enjoy the best possible quality of life.
Dr. Lewis has deep expertise in conducting clinical trials examining diagnostic and therapeutic approaches to heart failure. He has done innovative work to create systems for incorporating quality of life measures for cardiovascular patients into electronic health records. This research has received support from the National Heart, Lung and Blood Institute and the National Institutes of Health.
Much of his quality of life research has focused on patient-reported outcomes. Dr. Lewis emphasizes the importance of looking at how a disease, whether chronic or acute, impacts people’s ability to function and perform their activities of daily living. Strategies to improve patients’ well-being focus not only on their physical symptoms but also on depression, anxiety, exercise capacity, and ability to function in daily living.
Dr. Lewis’ commitment to expanding clinical research initiatives will give patients more opportunities to participate in the clinical trials and access the latest care strategies that can translate into better outcomes. The goal is early access to the most advanced technology, pharmacology, and device therapy that can change outcomes for the better. He also envisions forming closer partnerships with community cardiologists and capitalizing further on Stanford’s proximity to and unique relationships with the digital technology leaders of Silicon Valley to enhance the use of digital technology for monitoring patients, optimizing treatment, and tracking outcomes.
He has authored nearly 200 articles published in peer-reviewed journals including the New England Journal of Medicine, Journal of the American College of Cardiology, Circulation, JAMA Cardiology, JAMA Internal Medicine, and many more. He is also on multiple editorial boards for cardiovascular journals and was an associate editor for Circulation–Heart Failure. In addition, he is an author of professional society clinical practice guidelines and scientific statements from both the American Heart Association (AHA) and the Food and Drug Administration.
Dr. Lewis’ honors for clinical care, scholarship, and research include the Joel Gordon Miller Award for community service and leadership from the University of Pennsylvania School of Medicine. He also was one of the first recipients of the Minority Faculty Development Award, which recognizes the research potential of young physicians. Dr. Lewis has received a grant from the Robert Wood Johnson Foundation to study the role of quality of life assessment in clinical decision making in patients with heart failure.
He is a fellow of the American College of Cardiology and the National American Heart Association (AHA) Research Committee. In addition, Dr. Lewis was as a member of the AHA Founders Affiliate Board of Directors, chair of the Council on Clinical Cardiology, and research chair of the Association of Black Cardiologists. He also serves on scientific committees to review grants for the AHA and on the FDA Task Force for the Standardization of Definitions for Endpoint Events in Cardiovascular Trials. -
Marc Ivan Lewis
Affiliate, Med/Program/Bedside Med
BiosDr. Marc Lewis is a rising second-year medical student at Meharry Medical College with interests in internal medicine, specifically allergy & immunology, endocrinology, and addiction medicine. His background ranges from behavioral neuroscience and neuropsychopharmacology to French linguistics and classroom teaching. For Summer 2026, sDr. Lewis will be working in the lab of Dr. Angela Rogers with Dr. Rogers and Dr. Andrew Moore.
-
Matt Lewis, MD, MPH
Clinical Associate Professor, Dermatology
BioDr. Lewis specializes in autoimmune skin diseases. He completed medical school at The George Washington University School of Medicine and dermatology residency at The University of Rochester, where he was chief resident. He also completed a Master’s of Public Health at Johns Hopkins and a fellowship in autoimmune connective tissue diseases at Stanford University.
He believes multidisciplinary care is key to treat patients with systemic inflammatory diseases. He holds a rheumatology-dermatology clinic with a rheumatologist, Dr. Janice Lin, as well as a dermatology-ophthalmology clinic with an ophthalmologist, Dr. Christopher Ta, and is the dermatologist for the sarcoidosis program, all with this primary goal of providing high quality, collaborative, patient-centered care. -
Richard Lewis
Professor of Molecular and Cellular Physiology, Emeritus
Current Research and Scholarly InterestsWe study molecular mechanisms of calcium signaling with a focus on store-operated CRAC channels and their essential roles in T cell development and function. Currently we aim to define the molecular mechanism for CRAC channel activation and the means by which calcium signal dynamics mediate specific activation of transcription factors and T-cell genes during development.
-
William Spencer Lewis, MD
Clinical Assistant Professor, Otolaryngology (Head and Neck Surgery)
BioA native of the south Bay Area, Dr. Lewis brings 25 years of professional experience in the field of otolaryngology. He graduated with highest honors from UC Davis in biochemistry, and he was elected to the Alpha Omega Alpha Honor Society at the University of Southern California School of Medicine. He is Board Certified in Otolaryngology, a Qualified Medical Evaluator, a licensed Hearing Aid Dispenser, and a licensed X-Ray Supervisor/Operator. Dr. Lewis is honored to be past-president of the Santa Clara County Medical Association and past Chief of the Medical Staff at Good Samaritan Hospital.
Dr. Lewis treats both children and adults for general ear, nose and throat diseases. He has a special interest in hearing and balance problems, including chronic ear infections, sudden hearing loss, balance problems and vertigo.
When not working, Dr. Lewis has an eclectic mix of interests. He enjoys sporting events and activities, including running, swimming, cycling, golfing and basketball. He finds satisfaction in do-it-yourself home projects, especially woodworking. Above all, he loves to get out into the great outdoors and commune with nature. -
April Leyson
Section Administrative Supervisor, Surgery - General Surgery
Current Role at StanfordAdministrative Associate
For Drs. Dan E. Azagury, Byrne Lee, Carolyn Seib, and Dr. George Poultsides
Stanford Department of Surgery
Section of Bariatric and Minimally Invasive Surgery
& Section of Surgical Oncology -
Alice Huai-Yu Li, MD
Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine
BioDr. Alice Huai-Yu Li is an anesthesiologist and pain management specialist at Stanford Health Care. She is also a clinical assistant professor in the Department of Anesthesiology, Perioperative and Pain Medicine, Division of Pain Management at Stanford University School of Medicine.
Dr. Li specializes in headache and orofacial pain conditions, offering advanced, personalized care for patients with complex and often debilitating pain syndromes. Her clinical expertise spans a wide range of disorders, including temporomandibular joint dysfunction (TMD), migraine, trigeminal neuralgia, and other forms of headache and orofacial pain.
She collaborates closely with her colleagues in dentistry, neurosurgery, otorhinolaryngology (ENT), neurology, and oral and maxillofacial surgery (OMFS) to ensure comprehensive and coordinated care. With this interdisciplinary approach, she works with each patient to help them feel better and improve their daily life. This includes creating a tailored treatment plan with healthy lifestyle modifications, prescription medications, and targeted procedures with fluoroscopic, ultrasound, and/or stimulation guidance.
Dr. Li’s research focuses on advancing the treatment of migraine and orofacial pain. She leads studies on cutting-edge neuromodulation technologies for both migraine prevention and acute rescue, as well as ultrasound- and stimulation-guided procedures to relieve TMD symptoms. Her work also includes developing a treatment algorithm for trigeminal neuralgia and exploring the use of large language models to help clinicians diagnose complex headache and orofacial pain disorders.
Dr. Li has authored more than a dozen peer-reviewed publications and has presented her work at national and international conferences for organizations including the American Academy of Pain Medicine, the American Society of Anesthesiologists, and the North American Neuromodulation Society. -
Andrew A. Li, MD
Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology
BioDr. Li is a board-certified, fellowship-trained gastroenterologist with Stanford Health Care. He is a clinical assistant professor in the Department of Medicine, Division of Gastroenterology and Hepatology at Stanford University School of Medicine.
A therapeutic endoscopy specialist, Dr. Li received fellowship training in gastroenterology, advanced endoscopy, and endoscopic surgery at Stanford University School of Medicine. He is board certified in internal medicine and gastroenterology.
Dr. Li specializes in advanced endoscopic procedures. His areas of expertise include endoscopic ultrasound (EUS), endoscopic retrograde cholangiopancreatography (ERCP), enteroscopy, endoscopic mucosal resection (EMR), and endoscopic submucosal dissection (ESD). He also specializes in esophageal peroral endoscopic myotomy (POEM), gastric peroral endoscopic myotomy (GPOEM), and Zenker’s diverticulum peroral endoscopic myotomy (ZPOEM).
In addition, he treats gastrointestinal cancers, including gastric (stomach) cancer and colon cancer. He is dedicated to helping patients by integrating leading-edge research and innovations with compassionate, patient-centered clinical care.
Dr. Li’s research interests include gastric cancer, innovations in advanced endoscopy and endoscopic surgery, and the application of artificial intelligence (AI) and other computational techniques for prevention, diagnoses, and treatments.
Dr. Li has published articles in the World Journal of Gastrointestinal Endoscopy, Gastrointestinal Endoscopy, and Endoscopy International Open. He has presented at national and international conferences held in Las Vegas; Washington, D.C.; and Seoul, Korea. In his many presentations, he has covered topics such as the prevention of gastric cancer and prevention of post-ERCP pancreatitis.
Dr. Li is a member of the American Society for Gastrointestinal Endoscopy, American College of Gastroenterology, American Gastroenterological Association, and American College of Physicians. -
Caiyun Grace Li
Member, Cardiovascular Institute
Current Role at StanfordSenior Research Scientist
-
Daniel Yuhang Li
Instructor, Medicine - Cardiovascular Medicine
BioI am a physician scientist in the Division of Cardiology at Stanford. My clinical interest is at the intersection of inflammation, autoimmunity and cardiovascular disease in a field called 'Cardio-Rheumatology'. Patients with rheumatologic diseases typically have an elevated cardiovascular disease risk profile along with an insidious onset. Moreover, with the ever-expanding biologic drug formulary for patients, it is important for us to characterize the cardiovascular effects of these medications. In my research, I believe that understanding how inflammatory and autoimmune mechanisms modify coronary artery disease can help us develop a novel perspective towards treating atherosclerosis beyond lipid lowering. My research goal is to advance novel therapeutics for atherosclerosis by leveraging my expertise in genetics, computational biology, and experience with diverse model organism perturbation models. My strategy employs a ‘systems’ approach, starting with human population variations at the genetic level and integrating findings across RNA, protein, and model organism studies. This comprehensive synthesis aims to grasp the overarching biological narrative, thereby facilitating the development of translational therapies that transform concepts from bench to bedside.
-
Dayan J. Li, MD, PhD
Clinical Scholar, Dermatology
Postdoctoral Scholar, Pediatric SurgeryCurrent Research and Scholarly InterestsWound healing, cutaneous fibrosis
-
Gordon Li, MD
Professor of Neurosurgery and, by courtesy, of Neurology and Neurological Sciences and of Otolaryngology - Head & Neck Surgery (OHNS)
Current Research and Scholarly Interests1.) My laboratory studies the biology of brain tumors with the goal of developing novel therapeutics for the treatment of malignant brain tumors and translating that research into clinical trials.
2.) My clinical interests include improving surgical techniques for brain tumor surgery, immunotherapy for the treatment of glioblastoma, and novel uses for stereotactic radiosurgery. -
Y. Howard Li
Postdoctoral Scholar, Ophthalmology
BioDr. Yuanhao Howard Li received his B.S. and Ph.D. in Brain and Cognitive Sciences at the University of Rochester, and he is currently a Postdoctoral Scholar in the Department of Ophthalmology at Stanford School of Medicine. His research is focused on how eye movements shape visual perception and how, in return, the oculomotor system utilizes eye movements to optimize visual information processing. His current projects apply eye-tracking and computational models to investigate and relationship between anatomical structure and oculomotor behavior in clinical populations with visual field impairment or abnormal motor control. This research aims to provide a better understanding of our brains and eyes, as well as potential applications in disease diagnosis and rehabilitation.
-
Jiawei Li
Postdoctoral Scholar, Cardiovascular Institute
BioMy research interests include organoids, engineering, and AI.
-
Jin Billy Li
Professor of Genetics
Current Research and Scholarly InterestsThe Li Lab is primarily interested in RNA editing mediated by ADAR enzymes. We co-discovered that the major function of RNA editing is to label endogenous dsRNAs as "self" to avoid being recognized as "non-self" by MDA5, a host innate immune dsRNA sensor, leading us to pursue therapeutic applications in cancer, autoimmune diseases, and viral infection. The other major direction of the lab is to develop technologies to harness endogenous ADAR enzymes for site-specific transcriptome engineering.
-
Lei Li
Postdoctoral Scholar, Psychiatry
BioPh.D., University of Electronic Science and Technology of China, Biomedical engineering 2024
B.E., University of Electronic Science and Technology of China, Biomedical engineering2019 -
Lingyin Li
Professor of Biochemistry
BioDr. Li is a professor in the Biochemistry Department and ChEM-H Institute at Stanford. She is also a core investigator of the Arc Institute. Her lab works on understanding biochemical mechanisms of the immunotransmitter cGAMP and harnessing it to treat cancer and autoimmunity. She majored in chemistry at University of Science and Technology of China and graduated with a B. En in 2003. She then trained with Dr. Laura Kiessling, a pioneer in chemical biology, at University of Wisconsin-Madison and graduated with a Ph.D in chemistry in 2010. She obtained her postdoctoral training with Dr. Timothy Mitchison at Harvard Medical School, who introduced her to the field of chemical immunology. She started her lab at Stanford in 2015.
-
Ron Li
Clinical Associate Professor, Medicine
BioRon Li is a Clinical Associate Professor of Medicine in the Division of Hospital Medicine and Center for Biomedical Informatics Research at Stanford University School of Medicine. As the Medical Informatics Director for Digital Health at Stanford Health Care, he provides medical and informatics direction for the health system's enterprise digital health portfolio, including expanding digital referral networks and virtual care modalities. He is also the founding Medical Director for Stanford Health Care at Home and the co-founder and Director for the Stanford Emerging Applications Lab (SEAL), which helps clinicians and staff build ideas into novel digital products that are prototyped and tested for care delivery at Stanford Health Care.
Ron's academic interests focus on the "delivery science" of new technological capabilities such as digital and artificial intelligence in healthcare and how to design, implement, and evaluate new tech enabled models of care delivery. Ron's work spans across multiple disciplines, including clinical medicine, data science, digital health, information technology, design thinking, process improvement, and implementation science. He has consulted for various companies in the digital health and artificial intelligence space. He is an attending physician on the inpatient medicine teaching service at Stanford Hospital and is the Associate Program Director for the Stanford Clinical Informatics Fellowship. -
Ruijiang Li
Associate Professor of Radiation Oncology (Radiation Physics)
Current Research and Scholarly InterestsMy lab's research is focused on the development of imaging and molecular biomarkers to improve cancer detection, diagnosis, prognostication, and prediction of therapy response. Our ultimate goal is to translate these biomarkers into clinical practice to guide optimal management and therapeutic decisions for precision cancer medicine.
-
Sally S. Li
Executive Director, Medicine - Med/Family and Community Medicine
Current Role at StanfordExecutive Director, Center for Asian Health Research and Education (CARE)
